Tevogen Bio Appoints IT Expert and Leader Mittul Mehta as Chief Information Officer and Head of Tevogen.ai Initiative
Tevogen Bio – October 23rd, 2023
Tevogen Bio – October 23rd, 2023
Tevogen Bio Congratulates Innovation and Public Health Advisory Board Chairperson, Professor Sten Vermund on Being Elected to Serve as President of the Global Virus Network
Tevogen Bio – October 12th, 2023
Tevogen Bio – October 12th, 2023
Tevogen Bio Introduces Tevogen.ai to Enhance Patient Accessibility and Accelerate Innovation Leveraging Artificial Intelligence
Tevogen Bio – October 10th, 2023
Tevogen Bio – October 10th, 2023
Semper Paratus Acquisition Corporation Files Registration Statement on Form S-4 in Connection with Proposed Business Combination with Tevogen Bio Inc
Tevogen Bio – Sept 14th, 2023
Tevogen Bio – Sept 14th, 2023
Tevogen Bio to Become Publicly Listed on NYSE via Business Combination with Semper Paratus Acquisition Corporation
Tevogen Bio – June 29th, 2023
Tevogen Bio – June 29th, 2023